ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 218 filers reported holding ALKERMES PLC in Q4 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $379,858 | -1.3% | 13,562 | +10.2% | 0.00% | 0.0% |
| Q2 2023 | $384,790 | -19.7% | 12,309 | -27.5% | 0.00% | 0.0% |
| Q1 2023 | $479,046 | +16.8% | 16,982 | +8.1% | 0.00% | 0.0% |
| Q4 2022 | $410,065 | +17.8% | 15,705 | +0.8% | 0.00% | 0.0% |
| Q3 2022 | $348,000 | -18.9% | 15,582 | +8.1% | 0.00% | 0.0% |
| Q2 2022 | $429,000 | +4.1% | 14,417 | -7.9% | 0.00% | 0.0% |
| Q1 2022 | $412,000 | +14.4% | 15,656 | +1.2% | 0.00% | 0.0% |
| Q4 2021 | $360,000 | +110.5% | 15,465 | +180.4% | 0.00% | – |
| Q3 2021 | $171,000 | +66.0% | 5,516 | +30.7% | 0.00% | – |
| Q2 2021 | $103,000 | +21.2% | 4,221 | -7.8% | 0.00% | – |
| Q1 2021 | $85,000 | +3.7% | 4,576 | +12.0% | 0.00% | – |
| Q4 2020 | $82,000 | +22.4% | 4,085 | +0.3% | 0.00% | – |
| Q3 2020 | $67,000 | +26.4% | 4,074 | +50.3% | 0.00% | – |
| Q2 2020 | $53,000 | +29.3% | 2,710 | -5.2% | 0.00% | – |
| Q1 2020 | $41,000 | – | 2,860 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 2,639,676 | $96,322,000 | 7.78% |
| Meditor Group Ltd | 892,400 | $32,564,000 | 6.11% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233,000 | $8,502,000 | 3.14% |
| Tamarack Advisers, LP | 140,000 | $5,109,000 | 2.03% |
| Asymmetry Capital Management, L.P. | 27,673 | $1,010,000 | 1.69% |
| First Light Asset Management, LLC | 211,164 | $7,705,000 | 1.00% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 304,992 | $11,129,000 | 0.85% |
| Nicollet Investment Management, Inc. | 28,020 | $1,022,000 | 0.67% |
| PRIMECAP MANAGEMENT CO/CA/ | 23,263,530 | $848,886,000 | 0.62% |
| Rhenman & Partners Asset Management AB | 120,399 | $4,393,000 | 0.51% |